
Richard H. Ebright is a Professor & Biosafety Accountability Advocate, ranked #2 in Science & Academia (Chemistry) (Top 18%).
Last updated
Richard H. Ebright is a Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University and the founder and CEO of APY Therapeutics, LLC. His public content primarily focuses on laboratory biosafety incidents, gain-of-function research, pandemic origins, and public health policy critiques. He frequently comments on the actions of figures such as Anthony Fauci, Jeffery Taubenberger, and others within the scientific and federal health establishment. His posts cite scientific analyses, congressional testimonies, and news reports, often highlighting risks of lab-generated pandemics and calling for accountability and reform in biosafety oversight.
All informed persons understood COVID likely entered through a research incident.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.